Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/MEDCL stock hub

EPA/MEDCL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/MEDCLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

941.4M

Euronext Paris

Market data

Live price

Current market quote for this ticker.

Current price

EPA/MEDCL

In the news

Latest news · EPA/MEDCL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-21

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/MEDCL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

EUR

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	145
Employees Change	14%
Employees Change Percent	10.69
Enterprise value	EUR 961.5M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0004065605
Last refreshed	2026-05-10
Market cap	EUR 941.4M
Price	EUR 26.22
Price currency	EUR
Rev Per Employee	223,717.24x
Sector	Healthcare
Sic	2834
Symbol	epa/MEDCL
Website	https://www.medincell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.12%
EV Earnings	-48.2x
EV/FCF	-54.39x
EV/Sales	29.64x
FCF yield	-1.88%
P/B ratio	-30.73x
P/S ratio	29.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-30.14%
EBITDA Margin	-29.5%
Gross margin	100%
Gross Profit	EUR 32.4M
Gross Profit Growth	16.99%
Gross Profit Growth Q	49.94%
Gross Profit Growth3 Y	39.52%
Gross Profit Growth5 Y	18.89%
Net Income	EUR -19.9M
Net Income Growth Years	2%
Pretax Margin	-61.38%
Profit Margin	-61.49%
Profit Per Employee	EUR -137,572
ROA	-9.16
Roa5y	-28.89
ROCE	-18.36
ROIC	-21.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	69.22%
Cagr3y	43.29%
Cagr5y	20.5%
EPS Growth Quarters	2
EPS Growth Years	2
Revenue Growth	145.75x
Revenue Growth Q	49.94x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	39.52x
Revenue Growth5 Y	18.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.49
Assets	EUR 74.6M
Cash	EUR 53.5M
Current Assets	EUR 61.4M
Current Liabilities	EUR 21.3M
Debt	EUR 73.6M
Debt FCF	EUR -4.16
Equity	EUR -30.6M
Interest Coverage	-1.84
Liabilities	EUR 105.2M
Long Term Assets	EUR 13.2M
Long Term Liabilities	EUR 83.9M
Net Cash	EUR -20.1M
Net Cash By Market Cap	EUR -2.13
Tangible Book Value	EUR -33.7M
Tangible Book Value Per Share	EUR -1.02
WACC	9.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.88
Net Working Capital	EUR -7.9M
Quick ratio	2.83
Working Capital	EUR 40M
Working Capital Turnover	EUR 1.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	69.16%
200-day SMA	24.46
3Y total return	194.28%
50-day SMA	23.04
50-day SMA vs 200-day SMA	50under200
5Y total return	154.07%
All Time High	39.68
All Time High Change	-33.92%
All Time High Date	2025-10-31
All Time Low	4.35
All Time Low Change	502.76%
All Time Low Date	2020-03-17
ATR	1.22
Beta	1
Beta1y	1.26
Beta2y	1.04
Ch YTD	4.05
High	26.4
High52	39.68
High52 Date	2025-10-31
High52ch	-33.92%
Low	25.8
Low52	14.5
Low52 Date	2025-05-12
Low52ch	80.83%
Ma50ch	13.8%
Price vs 200-day SMA	7.19%
RSI	62.76
RSI Monthly	60.09
RSI Weekly	55.5
Sharpe ratio	1.24x
Sortino ratio	2.01
Total Return	-8.92%
Tr YTD	4.05
Tr1m	20.94%
Tr1w	6.93%
Tr3m	10.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -9.8M
Operating margin	-30.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	32,783,114%
Net Borrowing	-5,330,000
Shares Insiders	4.06%
Shares Institutions	24.52%
Shares Out	35,904,117
Shares Qo Q	9.66%
Shares Yo Y	8.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -21M
Average Volume	114,908.1x
Bv Per Share	-0.93
CAPEX	EUR -782,000
Ch1m	20.94
Ch1w	6.93
Ch1y	69.16
Ch3m	10.35
Ch3y	194.3
Ch5y	154.1
Ch6m	-17.03
Change	-0.46%
Change From Open	-0.61
Close	26.34
Days Gap	0.15
Depreciation Amortization	207,000
Dollar Volume	1,436,803.6
Earnings Date	2026-06-16
EBIT	EUR -9.8M
EBITDA	EUR -9.6M
EPS	EUR -0.63
F Score	3
FCF	EUR -17.7M
FCF EV Yield	-1.84x
FCF Per Share	EUR -0.49
Financing CF	32,888,000
Fiscal Year End	March
Founded	2,003
Income Tax	EUR 37,000
Investing CF	2,146,000
Is Primary Listing	1
Last Earnings Date	2025-12-09
Last Report Date	2025-09-30
Ma150	26.42
Ma150ch	-0.77%
Ma20	24.47
Ma20ch	7.15%
Net CF	18,131,000
Next Earnings Date	2026-06-16
Open	26.38
Position In Range	70
Ppne	4,842,000
Price Date	2026-05-08
Relative Volume	0.48x
Revenue	32,439,000x
SBC By Revenue	10.37x
Share Based Comp	3,363,000
Tax By Revenue	0.11x
Tr6m	-17.03%
Volume	54,798
Z Score	3.26

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/MEDCL pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/MEDCL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/MEDCL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.5%

Share of float held by funds and institutions

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+8.9%

Negative means the company is buying back shares.

Technical

EPA/MEDCL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.8

Neutral momentum band

Price vs 200-day MA

+7.2%

50/200-day relationship not available

Beta (5Y)

1.00

Moves roughly with the market

Sharpe ratio

1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/MEDCL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/MEDCL stock rating?

epa/MEDCL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/MEDCL analysis?

The full report lives at /stocks/epa/MEDCL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/MEDCL?

The latest report frames epa/MEDCL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/MEDCL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.